Markets this week showed a clear split: an exceptional earnings performance from a leading memory-chip company ran into broader flows moving away from technology and toward defensive sectors. At the same time, a slide in Bitcoin beneath the $60,000 mark translated into marked weakness for companies with leveraged exposure to the cryptocurrency.
Micron Technology
Micron was the earnings highlight, producing a fiscal third-quarter result that materially exceeded expectations. The company reported EPS of $25.11 versus a consensus forecast of $20.49 and posted revenue of $41.46 billion compared with the $35.69 billion consensus. Micron's fourth-quarter revenue guidance of $49 billion to $51 billion likewise came in well ahead of the $43.24 billion consensus. The stock initially jumped more than 15% on the earnings beat before settling back to finish the week roughly 5% higher.
DA Davidson analyst Gil Luria responded by increasing his price target to $2,000 from $1,500 while keeping a Buy rating. In Luria's view, "We posit that Micron has entered an era where it has some of the semi industry's best visibility," and he added that the analyst expects tight supply-demand dynamics to persist through at least 2027.
Apple
Apple shares declined 6.4% over the past week after reports indicated the company is implementing price increases of 15% to 25% across Macs, iPads, and accessories. Morgan Stanley analyst Erik Woodring characterized the scale of these increases as unprecedented over at least the last 15 years outside of isolated model-level changes. Woodring suggested the magnitude of the hikes indicates Apple is defending gross margins against record memory cost inflation rather than merely passing costs through to customers.
ON Semiconductor and Synaptics
ON Semiconductor's stock plunged about 24% on Friday following an announcement that it will acquire Synaptics in an all-stock transaction, valuing the deal at approximately $7 billion in enterprise value. That price represents roughly a 19% premium to Synaptics' recent trading average. TD Cowen analyst Joshua Buchalter downgraded ON from Buy to Hold and trimmed his price target to $110 from $115, saying, "We believe in the organic auto/DC growth and cap return story but think the deal adds complexity to an already complicated model."
Strategy
The company identified as Strategy experienced a decline of more than 28% during the week as Bitcoin fell below $60,000. The slide underscored Strategy's leveraged exposure to the cryptocurrency and renewed concerns about the company's balance sheet when coin prices are depressed.
Large-cap Pharmaceuticals
As investors rotated away from technology, the large-cap pharmaceutical sector attracted capital. Defensive names delivered notable gains over the last week: Johnson & Johnson rose 9.4%, Merck gained 11.4%, and Eli Lilly advanced 7.6%, including a rally of more than 6% on Friday. The sector's strength was driven by its status as a defensive destination amid broader market uncertainty.
Overall, the week's market action was characterized by a divergence between company-specific upside tied to earnings and guidance - most prominently in the memory-chip space - and a broader repositioning of portfolios toward defensive, lower-volatility sectors. The retreat in Bitcoin also served as a key driver of stress among crypto-linked names.